Sort by
Refine Your Search
-
chemical biology. Our mission is to understand and reprogram protein assemblies that control chromosome segregation and behavior. Applicants with expertise in structural biology or chemical biology are
-
Stanford University required minimum for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY25 minimum is $76,383. The Human Motor Control and Neuromodulation Lab under Dr
-
and clinical measures in collaboration with domain experts Managing structured datasets in REDCap and maintaining reproducible, version-controlled workflows Leading methods-driven manuscripts and
-
-to-end experimental paradigms, including behavioral training and tracking, multi-Neuropixels recordings, imaging- and function-based recording path registration, and data quality control pipelines
-
thermodynamic, kinetic, and transport phenomena. - Optimize the design and control of electrified processes to effectively manage the heterogeneous and dynamic feed compositions associated with non-traditional
-
, curating and analyzing a deeply-phenotyped dementia and healthy older control dataset. We have generated over 1200 long-read sequencing (LRS) genomes of diverse phenotypes and have additional multiomic data
-
decision support systems, process control and quality improvement initiatives, and health policy analysis. The program emphasizes both methodological rigor and translational impact, with projects addressing
-
. RESEARCH IN THE LAB We are a team of structural and chemical biologists interested in how cells control metabolism in response to nutrients. We ask how nutrients are recognized by their protein sensors, how
-
maintaining protocols for analyses and quality control Pursuing independent research projects related to lead contamination and/or environmental health topics (up to 10% time). Required Qualifications: PhD in a
-
to advance the understanding of IBD pathogenesis Perform ex vivo and in vitro studies using human intestinal tissue and peripheral blood-derived epithelial and immune cells from IBD patient and controls